NovoCure Ltd (NASDAQ: NVCR) has recently experienced extremely important negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, the stock fell on very heavy volume, its longer term price […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $19.23 on 2/27/25 after a major decline of -12.4%. Moreover, this decline was accompanied by exceptionally high trading volume at 312% of normal. The stock has declined -11.8% […]
On 12/13/24, NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 11.1%, closing at $33.41. Moreover, this advance was accompanied by above average trading volume at 121% of normal. The stock has been strong […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $19.69 on 11/27/24 after a major increase of 10.1%. This advance was accompanied by normal trading volume. The stock has risen 19.5% during the last week and has […]
On 10/31/24, NovoCure Ltd (NASDAQ: NVCR) stock suffered a major decline of -10.7%, closing at $15.18. This decline was accompanied by normal trading volume. The stock has declined -6.2% during the last week but has […]
For its third fiscal quarter (ending September 30), NovoCure Ltd (NASDAQ: NVCR) has reported a -39% decline in E.P.S. from $-0.46 a year ago to $-0.28 in the current quarter. E.P.S. were $-1.40 for the […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $17.78 on 10/15/24 after a major increase of 10.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 281% of normal. The stock has risen 21.7% […]
NovoCure Ltd (NASDAQ: NVCR) stock closed at $16.75 on 9/3/24 after a major decline of -13.8%. Moreover, exceptionally high trading volume at 204% of normal accompanied the decline. Relative to the market the stock has […]
NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 12.2% on 7/30/24. The shares closed at $23.34. Moreover, trading volume in this advance was unusually high at 191% of normal. The stock has risen […]
For its second fiscal quarter (ending June 30), NovoCure Ltd (NASDAQ: NVCR) has reported E.P.S. of $-0.31 compared to $-0.54 a year ago. This performance was $0.09 better than the consensus estimate of $-0.40. E.P.S. […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research